TG Therapeutics, Inc. - Special Call Transcript
Greetings, and welcome to the TG Therapeutics AACR Data Update Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Michael S. Weiss, Chief Executive Officer in TG Therapeutics. Thank you. You may begin.
Thank you, Ena. Thanks, everyone, for joining us today. We're very excited about the news this morning and the presentation.
Before I get started, let me just mention that we may or will be making some forward-looking statements. And as usual, anyone who is interested, we do encourage you to look at our public disclosure documents and the risk factors available on the Internet.
So we've got a special guest today. The way this is going to work, Dr. Fowler is going to give the same presentation that he gave this morning for the press conference and the presentation he'll give this afternoon to the larger audience at AACR. So that's a very special treat we've arranged.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |